Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02602119 · ClinicalTrials.gov registry record · Phase 1
Intraoperative Imaging of Pulmonary Nodules by OTL38
A Phase 1 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 1
- Development phase
- 262
- Enrollment target
NCT02602119: Completed Phase 1 study, sponsored by University of Pennsylvania.
NCT02602119 is a Phase 1 study that has completed, run by University of Pennsylvania. The registered enrollment target is 262 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (337% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02602119, a Phase 1 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 262 participants
- Enrollment target
Study Summary
The primary end-point of the study is to determine the sensitivity of OTL in identifying lung nodules when excited by an imaging probe. Investigators intend to enroll 300 lung cancer patients in this study. The study is focusing on patients presenting with suspected malignancies of the lung and pleura who are considered to be good surgical candidates.
Primary Outcome
Detected with imaging probe.
Interventions
- DRUG OTL38
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 262 participants |
| Start Date | 2015-05 |
| Est. Completion | 2022-05 |
| Phase | Phase 1 |
What the finished NCT02602119 record still lists
NCT02602119 is an interventional study that assigns participants to a tested intervention. The registered 262 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (337% higher).
The record links to 0 conditions, and to 1 intervention - of which OTL38 is the first listed.
NCT02602119 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02602119 about?
NCT02602119 is a clinical study titled "Intraoperative Imaging of Pulmonary Nodules by OTL38". The primary end-point of the study is to determine the sensitivity of OTL in identifying lung nodules when excited by an imaging probe. Investigators intend to enroll 300 lung cancer patients in this study. The study is focusing on patients presenting with suspected malignancies of the lung and pleu...
What is the current status of trial NCT02602119?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 262 participants. The study started on 2015-05. Estimated completion is 2022-05.
What interventions are being tested in trial NCT02602119?
The interventions under investigation include: OTL38 (DRUG).
Who is sponsoring clinical trial NCT02602119?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02602119's enrollment target sits among peer trials
262 159th of 2000 higher than 1,841 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03713268 · 262 participants
Intraoperative OCT Guidance of Intraocular Surgery II
- NCT06074380 · 262 participants · Phase 4
Non Inferiority Trial Investigating Surfactants Administered Via MIST
- NCT06293703 · 262 participants · NA
Effect of Limb Length Ratio on Roux-en-Y Gastric Bypass Outcomes (CLIMB II Study)
- NCT06780137 · 262 participants · Phase 1
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia